Plato Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$782K Hold
11,681
– – 0.04% 306
2026
Q1
$734K Sell
11,681
-2,683
-19% -$187K 0.05% 308
2025
Q4
$958K Hold
14,364
– – 0.06% 268
2025
Q3
$959K Buy
14,364
+44
+0.3% +$3.48K 0.07% 267
2025
Q2
$1.25M Buy
14,320
+3
+0% +$235 0.09% 222
2025
Q1
$988K Sell
14,317
-1,176
-8% -$96K 0.08% 246
2024
Q4
$1.21M Buy
15,493
+7,890
+104% +$584K 0.09% 233
2024
Q3
$509K Sell
7,603
-5,802
-43% -$476K 0.04% 315
2024
Q2
$1.52M Sell
13,405
-358
-3% -$45.3K 0.14% 156
2024
Q1
$1.91M Buy
13,763
+11,346
+469% +$1.43M 0.2% 125
2023
Q4
$300K Buy
+2,417
New +$247K 0.37% 70

Other funds holding DXCM

Plato Investment Management's DXCM Position: Q2 2026 in Review

Plato Investment Management held its DexCom (DXCM) position steady in Q2 2026 at 11,681 shares worth $782K. The position accounts for 0.04% of the portfolio, ranked #306.

Plato Investment Management first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.91M in Q1 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Plato Investment Management held 11,681 shares of DexCom worth $782K as of Q2 2026.
  • Plato Investment Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.04% of Plato Investment Management's portfolio in Q2 2026, its #306 holding.
  • Plato Investment Management first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's DexCom position peaked at $1.91M in Q1 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.